Acute effects of alcohol septal ablation on systolic and diastolic left ventricular function in patients with hypertrophic obstructive cardiomyopathy

Heart

Volumn 94, Issue 10, 2008, Pages 1318-1322

  Steendijk, P ^a   Meliga, E ^b,c   Valgimigli, M ^b   Ten Cate F J , ^b   Serruys, P W ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ADULT; ARTICLE; BALLOON DILATATION; CLINICAL ARTICLE; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HEART CATHETER; HEART HEMODYNAMICS; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE; HEART OUTPUT; HEART RATE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART WORK; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL SEPTAL MYOCARDIAL ABLATION; PRIORITY JOURNAL; THERAPY EFFECT; TRANSTHORACIC ECHOCARDIOGRAPHY;

BALLOON DILATATION; CARDIOMYOPATHY, HYPERTROPHIC; ETHANOL; FEMALE; HEMODYNAMICS; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; SOLVENTS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 52649157008     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.139535     Document Type: Article

References (40)

1. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-20.
2. Maron MS, Olivotto I, Betocchi S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome In hypertrophic cardiomyopathy. N Engl J Med 2003;348:295-303.
3. Autore C, Bernabo P, Barilla CS, et al. The prognostic importance of left ventricular outflow obstruction In hypertrophic cardiomyopathy varies in relation to the severity of symptoms. J Am Coll Cardiol 2005;45:1076-80.
4. Deb SJ, Schaff HV, Dearani JA, et al. Septal myectomy results in regression of left ventricular hypertrophy in patients with hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 2004;78:2118-22.
5. Van der Lee C, ten Cate FJ, et al. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cariomyopathy and enlarged anterior mitral valve leaflets. Circulation 2005;112:482- 8.
6. Seggewiss H, Gleichmann U, Faber L, et al. Percutaneous transluminal septal myocardial ablation In hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998;31:252-8.
7. Faber L, Meissner A, Ziemssen P, et al. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients. Heart 2000;83:326-31.
8. Abbas AE, Brewington SD, Dixon SB, ey al. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. J Interv Cardiol 2005;18:155-62.
9. Zeng Z, Wang F, Dou X, et al. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy - a meta analysis. Int J Cardiol 2006;112:80-4.
10. Knight CJ. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Heart 2006:92:1339-1414.
11. Flores-Ramirez R, Lakkis NM, Middleton KJ, et al. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001;37:208-14.
12. Oomman A, Ramachandran P, Subramanyan K, et al. Percutaneous transluminal septal myocardial ablation in drug-resistant hypertrophic obstructive cardiomyopathy: 18-month follow-up results. J Invasive Cardiol 2001;13:526-30.
13. Faber L, Welge D, Fassbender D, et al. One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response. Clin Res Cardiol 2007;96:864-73.
14. Takeuchi M, Igarashi Y, Tomimoto S, et al. Single-beat estimation of the slope of the end-systolic pressure-volume relation In the human left ventricle. Circulation 1991;83:202-12.
15. Morrow AG, Brockenbrough EC. Surgical treatment of idiopathic hypertrophic subaortic stenosis: technique and hemodynamic results of subaortic ventriculotomy. Ann Surg 1961:154:181.
16. Teare RD. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 1958;20:1-8.
17. Spirito P, Rapezzi C, Autore C, et al. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. Circulation 1994;90:2743-7.
18. Chang AC, McAreavey D, Fananapazir L. Identification of patients with hypertrophic cardiomyopathy at high risk for sudden death. Curr Opin Cardiol 1995;10:9-15.
19. Sherrid MV, Barac I, McKenna WJ, et al. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005;45:1251-8.
20. Meisel E, Rauwolf T, Burghardt M, et al. Pacemaker therapy of hypertrophic obstructive cardiomyopathy. Pacing in Cardiomyopathy Study Group. Herz 2000;25:461-6.
21. Pak PH, Maughan WL, Baughman KL, et al. Mechanism of acute mechanical benefit from VDD pacing in hypertrophied heart: similarity of responses in hypertrophic cardiomyopathy and hypertensive heart disease. Circulation 1998;98:242-8.
22. Mohri M, Ichiki T, Kuga T, et al. Evidence for anti-ischemic effect of dual-chamber pacing in patients with the obstructive form of hypertrophic cardiomyopathy. Jpn Heart J 2003;44:587-92.
23. Ralph-Edwards A, Woo A, McCrindle BW, et al. Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. J Thorac Cardiovasc Surg 2005;129:351-8.
24. Baggish AL, Smith BN, Palacios I, et al. Pathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Heart 2006;92:1773-8.
25. Yoerger DM, Picard MH, Palacios IF, et al. Time course of pressure gradient response after first alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol 2006;97:1511-4.
26. Song JM, Fukuda S, Lever HM, et al. Asymmetry of systolic anterior motion of the mitral valve In patients with hypertrophic obstructive cardiomyopathy: a real-time three-dimensional echocardiographic study. J Am Soc Echocardiogr 2006; 19:1129-35.
27. Jassal DS, Neilan TG, Fifer MA, et al. Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Eur Heart J 2006;27:1805-10.
28. Airoldi F, Di Mario C, Catanoso A, et al. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy. Ital Heart J 2000;1:200-6.
29. De Gregorio C, Recupero A, Grimaldi P, et al. Can transthoracic live 3-dimensional echocardiography improve the recognition of midventricular obliteration in hypertrophic obstructive cardiomyopathy? J Am Soc Echocardiogr 2006; 19 :1190 e1-4.
30. Sitges M, Qin JX, Lever HM, et al. Evaluation of left ventricular outflow tract area after septal reduction in obstructive hypertrophic cardiomyopathy: a real-time 3-dimensional echocardiographic study. Am Heart J 2005;150:852-8.
31. Amano Y, Takayama M, Amano M, et al. MBI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Am J Roentgenol 2004;182:523-7.
32. Sitges M, Shiota T, Lever HM, et al. Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy. Am J Cardiol 2003:91:817-21.
33. Veselka J, Honek T. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Int J Cardiol 2003:88:27-32.
34. Yacoub MH. Surgical versus alcohol septal ablation for hypertrophic obstructive cardiomyopathy: the pendulum swings. Circulation 2005;112:450-2.
35. Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol 2005;289:H501-12.
36. Gillebert TC, Leite-Moreira AF, De Hert SG. Load dependent diastolic dysfunction in heart failure. Heart Fail Rev 2000;5:345-55.
37. Brutsaert DL. Diastolic heart function and dysfunction. Rev Port Cardiol 1999;18(Suppl 5):V11-5.
38. Brutsaert DL, Sys SU. Relaxation and diastole of the heart. Physiol Rev 1989;69:1228-315.
39. Brimioulle S, Wauthy P, Ewalenko P, et al. Single-beat estimation of right ventricular end-systolic pressure-volume relationship. Am J Physiol Heart Circ Physiol 2003;284:H1625-30.
40. Klotz S, Hay I, Dickstein ML, et al. Single-beat estimation of end-diastolic pressure-volume relationship: a novel method with potential for noninvasive application. Am J Physiol Heart Circ Physiol 2006;291:H403-12.